311969
Psychometric structure of the short Internalized Homonegativity scale in 38 European countries
Methods: Eight items of the short IH scale were measured by a 7-point Likert score. Subsample of EMIS data including 125,841 respondents as randomly split into two halves: a training dataset and a testing dataset. By using Confirmation Factor Analysis, IH structure was developed in the training dataset, and validated in the testing dataset. The IH scale’s configural invariance, scalar invariance, residual invariance, and structural invariance were accessed across training and testing datasets, and across age, education, and country subgroups.
Results/Conclusions: an IH structure was developed with the fit indexes CFI=0.99, TLI=0.983, and RMSEA=0.03. This model was confirmed when it was equivalent between two halves of datasets, and between age and education subgroups. The intercepts of two items was variant across country subgroups, indicating the partly equivalence. These results suggest the appropriateness of this IH scale and structure for European MSM and can be used for future studies.
Learning Areas:
EpidemiologySocial and behavioral sciences
Learning Objectives:
Identify the structural model of Internalised Homonegativity (IH) using Confirmation Factor Analysis based on eight measured items;
Access the validation of developed IH structure by using measurement and structural invariance tests across two halves of the subsample of the European Men-Who-Have-Sex-With-Men (MSM) Internet Survey (EMIS) data;
Assess the measurement and structural invariance of IH structure across age, education, and country subgroups.
Keyword(s): HIV/AIDS, Sexuality
Qualified on the content I am responsible for because: I have been the researcher who has constructed the psychometric structure of the short Internalized Homonegativity scale by analyzing the European Men-Who-Have-Sex-With-Men Internet Survey (EMIS) data
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.